Related Experiment Videos
Computer-assisted quantitation of enhancing lesions in multiple sclerosis: correlation with clinical classification
Y Miki1, R I Grossman, J K Udupa
1Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia 19104, USA.
AJNR. American Journal of Neuroradiology
|April 1, 1997
Summary
Computer-assisted analysis quantifies multiple sclerosis (MS) lesions, showing higher lesion volume in relapsing-remitting MS. This objective method tracks disease activity over time.
Area of Science:
- Neurology
- Medical Imaging
- Biostatistics
Background:
- Multiple Sclerosis (MS) is a chronic neurological disease.
- Accurate quantitation of disease activity is crucial for MS management.
- Current methods for lesion quantitation can be subjective and time-consuming.
Purpose of the Study:
- To evaluate a computer-assisted method for quantifying enhancing lesions in MS.
- To correlate lesion quantitation with MS disease type and duration.
- To assess the utility of this method in reflecting disease activity.
Main Methods:
- Forty untreated MS patients (27 relapsing-remitting, 13 chronic-progressive) were studied.
- Postcontrast MRI scans were analyzed using 3DVIEWNIX software with "fuzzy connectedness" for lesion detection.
- Computer-assisted analysis computed the number and volume of enhancing lesions.
Main Results:
- Enhancing lesion volume was significantly higher in relapsing-remitting MS compared to chronic-progressive MS.
- A strong positive correlation was observed between the number and volume of enhancing lesions.
- No significant correlation was found between changes in disability scores (EDSS) and lesion burden; however, negative correlations existed between lesion burden and disease duration.
Conclusions:
- Computer-assisted quantitation of enhancing lesion volume is a practical and objective measure of MS activity.
- Enhancing lesion volume reflects differences in clinical MS classification and disease activity over time.
- This method provides a robust tool for monitoring MS progression and treatment response.